No effect of levothyroxine on hemoglobin in older adults with subclinical hypothyroidism: pooled results from 2 randomized controlled trials

Du Puy, R. S. et al. (2022) No effect of levothyroxine on hemoglobin in older adults with subclinical hypothyroidism: pooled results from 2 randomized controlled trials. Journal of Clinical Endocrinology and Metabolism, 107(6), e2339-e2347. (doi: 10.1210/clinem/dgac106) (PMID:35218666)

[img] Text
266633.pdf - Published Version
Available under License Creative Commons Attribution Non-commercial No Derivatives.

246kB

Abstract

Context: Subclinical thyroid dysfunction and anemia are common disorders, and both have increasing prevalence with advancing age. Objective: The aim of this study was to assess whether levothyroxine treatment leads to a rise in hemoglobin levels in older persons with subclinical hypothyroidism. Methods: This preplanned combined analysis of 2 randomized controlled trials included community-dwelling persons aged 65 years and older with subclinical hypothyroidism who were randomly assigned to levothyroxine or placebo treatment. The levothyroxine dose was periodically titrated aiming at thyroid stimulating hormone (TSH) level within the reference range, with mock titrations in the placebo group. The main outcome measure was the change in hemoglobin level after 12 months. Results: Analyses included 669 participants (placebo n = 337, levothyroxine n = 332) with a median age of 75 years (range, 65-97) and mean baseline hemoglobin of 13.8 ± 1.3 g/dL. Although levothyroxine treatment resulted in a reduction in TSH from baseline after 12 months of follow-up compared with placebo, the change in hemoglobin level was not different between the levothyroxine and the placebo groups (−0.03 g/dL [95% CI, −0.16 to 0.11]). Similar results were found in stratified analyses including sex, age, or TSH levels. No difference in change of hemoglobin levels after 12 months was identified in 69 participants with anemia at baseline (−0.33 g/dL [95% CI, −0.87 to 0.21]). Conclusion: In persons aged 65 years and older with subclinical hypothyroidism, treatment with levothyroxine does not lead to a rise in hemoglobin levels, regardless of the presence of anemia.

Item Type:Articles
Keywords:Biochemistry (medical), Clinical Biochemistry, Endocrinology, Biochemistry, Endocrinology, Diabetes and Metabolism
Status:Published
Refereed:Yes
Glasgow Author(s) Enlighten ID:Quinn, Dr Terry and Stott J, Professor David and Sattar, Professor Naveed
Authors: Du Puy, R. S., Poortvliet, R. K. E., Mooijaart, S. P., Stott, D. J., Quinn, T., Sattar, N., Westendorp, R. G. J., Kearney, P. M., McCarthy, V. J. C., Byrne, S., Rodondi, N., Baretella, O., Collet, T.-H., van Heemst, D., Dekkers, O. M., Jukema, J. W., Smit, J. W. A., Gussekloo, J., and den Elzen, W. P. J.
College/School:College of Medical Veterinary and Life Sciences > School of Cardiovascular & Metabolic Health
Journal Name:Journal of Clinical Endocrinology and Metabolism
Publisher:Oxford University Press
ISSN:0021-972X
ISSN (Online):1945-7197
Published Online:26 February 2022
Copyright Holders:Copyright © 2022 The Author(s)
First Published:First published in Journal of Clinical Endocrinology and Metabolism 107(6): e2339-e2347
Publisher Policy:Reproduced under a Creative Commons License

University Staff: Request a correction | Enlighten Editors: Update this record